Address: Montes Urales 715 PB, Lomas de Chapultepec, Mexico D.F.
,Mexico
Tel: +52 55 5002 6686
Web: http://www.novonordisk.com.mx/documents/home_page/document/index.asp
Novo Nordisk is a world leader in the treatment of diabetes. It offers a complete range of products in the pharmaceutical industry for diabetes, including the most advanced insulin delivery systems that are preferred by patients and health professionals all over the world. In addition, Novo Nordisk has a leading position in other therapeutic areas, such as, haemostasis, growth hormones and hormone replacement therapy. Novo Nordisk manufactures and markets products and services designed to improve the quality of life for patients, health professionals and society in general. The company’s overall strategy is to generate profitable growth in three therapeutic areas: diabetes, growth hormone deficiencies and haemophilia. All of this rests on a strong foundation of shared values: The Novo Nordisk Way, a value-based management system. With the increasing severity of diabetes in Mexico, Novo Nordisk is committed more than ever to combating the disease, and will continue to work hard to be the leader in the Mexican market.
Innovative products for diabetes, growth hormone deficiencies and haemophilia
In Mexico, more than 13 million people live with diabetes, while 71 percent of the total population have obesity or are overweight. Morten Vaupel, vice-president and general manager of Novo…
Novo Nordisk’s market access and public affairs director discusses the state of diabetes management in Mexico, highlighting the government’s recent commitment to tackle this public health issue and the company’s…
Mexico is number one in child obesity and number two in adult obesity in the world. This is one of the reasons that diabetes is rapidly increasing and the Mexican…
Abelardo Meneses García, General Director at the National Cancer Institute of Mexico (INCan), explains the evolution of cancer’s footprint in Mexico and showcases how the institute has been investing in…
José Luis Hernández, general manager at Kedrion Mexico, explains the strategy followed by the affiliate in Mexico to obtain success during the past eight years and showcases the added value…
Maarten Pouw, business unit director of Mexico and Latin America at DSM Sinochem Pharmaceuticals, explains the crucial role that sustainable antibiotics play in combating antimicrobial resistance and showcases the company’s…
GM Gerardo Torres-Septién explains how Grupo Rasch has managed to grow during the last two years and showcases the added value of its solutions to help the pharmaceutical industry enhance…
Juan Francisco Hernández, general manager of Latin America at Wockhardt, showcases the added value of the company to the entire region based on quality, safety and cost-effective medicines targeting diabetes,…
María Teresa Lopez, managing director at Zimmer Biomet Mexico, discusses the medtech company’s strong commitment to Mexico as well as the high added value of its broad and innovative health…
Alberto Wicker, CEO at Signufarma, explains how patient compliance programs can enhance the national healthcare system through reducing the cost of treatment as well as improving patients’ quality of life…
Ricardo Amtmann, President at Laboratorios Sanfer, explains how they have grown their business by 100 percent throughout the last three years and showcases the added value of Sanfer to patients…
Patricia López, general manager at seca Mexico, showcases the added value of seca’s product portfolio and explains that interconnectivity should be medical devices’ path of development; generating benefits for patients,…
Patrick Troop, CEO at Pharma Tycsa, explains the company’s unique business approach in Mexico developing “clinical pharmacies” model to address chronic diseases treatment in the points of care and the…
Victor Manuel Fernández Navarro, CEO at Vicma, explains how strategically important is to have a healthy business model in the distribution industry through sustainable collection period, attractive profit margins and…
Dr. Marco A. Martinez Rios, General Director of the National Institute of Cardiology in Mexico elaborates on the institution’s rich history in Mexico and its contributions to cardiology through research,…
See our Cookie Privacy Policy Here
